A shadowy global industry group is deciding food standards for you
The Economics Times
September 17, 2019
Andrew Jacobs
When the Indian government bowed to powerful food companies last year
and postponed its decision to put red warning labels on unhealthy packaged
food, officials also sought to placate critics of the delay by creating an
expert panel to review the proposed labeling system, which would have gone far
beyond what other countries have done in the battle to combat soaring obesity
rates.
But the man chosen to head the three-person committee, Dr. Boindala
Sesikeran, a veteran nutritionist and former adviser to Nestle, only further
enraged health advocates.
That’s because Sesikeran is a trustee of the International Life Sciences Institute, a U.S. nonprofit with an innocuous sounding name that has been quietly infiltrating government health and nutrition bodies around the world.
Created four decades ago by a top Coca-Cola executive, the institute now has branches in 18 countries. It is almost entirely funded by Goliaths of the agribusiness, food and pharmaceutical industries.
The organization, which championed tobacco interests during the 1980s and 1990s in Europe and the United States, has more recently expanded its activities in Asia and Latin America, regions that provide a growing share of food company profits. It has been especially active in China, India and Brazil, the world’s first, second and sixth most populous nations.
That’s because Sesikeran is a trustee of the International Life Sciences Institute, a U.S. nonprofit with an innocuous sounding name that has been quietly infiltrating government health and nutrition bodies around the world.
Created four decades ago by a top Coca-Cola executive, the institute now has branches in 18 countries. It is almost entirely funded by Goliaths of the agribusiness, food and pharmaceutical industries.
The organization, which championed tobacco interests during the 1980s and 1990s in Europe and the United States, has more recently expanded its activities in Asia and Latin America, regions that provide a growing share of food company profits. It has been especially active in China, India and Brazil, the world’s first, second and sixth most populous nations.
In China, the institute shares both staff and office space with the
agency responsible for combating the country’s epidemic of obesity-related
illness. In Brazil, ILSI representatives occupy seats on a number of food and
nutrition panels that were previously reserved for university researchers.
And in India, Sesikeran’s leadership role on the food labeling committee has raised questions about whether regulators will ultimately be swayed by processed food manufacturers who say the red warning labels would hurtsales.
“What could possibly go wrong?” Amit Srivastava, the coordinator of the advocacy group India Resource Center, asked sarcastically. “To have a covert food lobby group deciding public health policy is wrong and a blatant conflict of interest.”
The organization rejects allegations that it works to advance the interests of its corporate members. “Under no circumstance does ILSI protect industry from being affected by disadvantageous policy and laws,” the group said in a statement.
After decades largely operating under the radar, ILSI is coming under
increasing scrutiny by health advocates in the United States and abroad who say
it is little more than a front group advancing the interests of the 400
corporate members that provide its $17 million budget, among them Coca-Cola,
DuPont, PepsiCo, General Mills and Danone.
Last year, the candy maker Mars withdrew from ILSI, saying it could no longer support an organization that funds what a Mars executive described as “advocacy-led studies.” In 2015, ILSI lost its special access to governing bodies at the World Health Organization after critics raised questions about its industry ties.
Last year, the candy maker Mars withdrew from ILSI, saying it could no longer support an organization that funds what a Mars executive described as “advocacy-led studies.” In 2015, ILSI lost its special access to governing bodies at the World Health Organization after critics raised questions about its industry ties.
In
the 40 years since its creation, ILSI has methodically cultivated allies in
academia and government through the conferences it sponsors around the world,
and by recruiting influential scientists to committees that work on issues like
food safety, agrochemicals or the promotion of probiotic supplements.
Although
conference topics seldom touch on politically contentious matters, critics say
they serve a larger purpose: cultivating scientists and officials who might
normally avoid an event directly sponsored by McDonald’s or Kellogg’s.
“It
also helps that they are always held at five-star hotels, and that they serve
you lunch,” said Dr. Shweta Khandelwal, a nutritionist with the nonprofit
Public Health Foundation of India. “We certainly don’t have the money to pay
for people’s lunch.”
In
many ways, Sesikeran is the ideal ILSI recruit: a former top government
official and marquee nutritionist. In the seven years since he retired as
director of India’s National Institute of Nutrition, Sesikeran has advised
companies like Nestle, the Japanese food giant Ajinomoto and the Italian
chocolate maker Ferrero.
Since
2015, Sesikeran has been a trustee of both ILSI-India and the organization’s
global operation based in Washington, and he is a frequent speaker at ILSI
events, where he has lectured about the benefits of artificial sweeteners and
genetically modified crops.
The
ILSI positions are unpaid, but they come with all-expense-paid travel to
meetings around the world.
Last
year, when the Food Safety and Standards Authority of India needed someone to lead
its panel on warning labels, officials chose Sesikeran. Pawan Kumar Agarwal,
the authority’s chief executive, had spoken at ILSI seminars alongside
Sesikeran, and in 2016, he tapped Sesikeran for a committee weighing the pros
and cons of genetically modified mustard plants.
ILSI’s
disclosure forms require board members to place the organization above all
other interests. Sesikeran did not respond to interview requests. Dr. Arun
Gupta, a pediatrician with Nutrition Advocacy in Public Interest-India, said
that in private, Sesikeran has defended his close association with industry,
saying he believed he could bring about needed change by working
with big food companies, not against them.
Rekha
Sinha, the longtime executive director of ILSI-India, said suggestions that the
organization promotes industry were wrong. In the two decades since its
founding, she said, ILSI-India had funded studies on diabetes, helped promote
the mandated fortification of processed food with vitamins, and advised the
government on how nutrition affects those with HIV and AIDS.
“The
criticisms of ILSI-India that are circulating out there are very painful
because they are not justified,” she said. As it expands across the globe, ILSI
is drawing unflattering attention. Over the past year, researchers have
documented how the organization’s China affiliate helped shape antiobesity education
campaigns that stressed physical activity over dietary changes, a strategy long
espoused by Coca-Cola that critics say is designed to protect corporate profits.
In
Beijing, relations between ILSI and the government are so intertwined that
ILSI’s top leaders double as senior officials at China’s Center for Disease
Control and Prevention.
Through
freedom of information requests, authors of a recent study in the United States
obtained emails between ILSI trustees, its corporate members and the group’s
allies in academia urging them to step up their fight against the WHO’s
increasingly tough stance on sugar.
In
one exchange in 2015, Alex Malaspina, the founder of ILSI, sought suggestions
from ILSI trustees and an official at the Centers for Disease Control and
Prevention in Atlanta about how to influence Dr. Margaret Chan, then the WHO’s
director-general.
“We
must find a way to start a dialogue,” wrote Malaspina, who retired as ILSI’s
president in 2001 but was still in frequent contact with its staff, trustees
and corporate members. “If not, she will continue to blast us with significant
negative consequences on a global basis.
This
threat to our business is serious.”
James
Hill, an ILSI trustee and expert on weight management, responded, “I agree that
we need to do something to try and prevent WHO from taking a completely
anti-food industry stance in the obesity field.”
In
a statement, ILSI, based in Washington, said claims that it sought to influence
the WHO were “unfounded and inaccurate.” Although it did not provide further
details or respond to specific questions about its activities overseas, the
organization said in another statement that ILSI entities are allowed to
provide regulators “information relating to factual matters within ILSI’s
scientific expertise.”
In
addition to its far-flung offices, ILSI runs a research foundation and an institute
focused on health and environmental issues that is largely funded by the
chemical industry. It also publishes the academic journal Nutrition Reviews and
organizes scores of scientific conferences around the world.
Much
of ILSI’s work in recent years has focused on fostering relationships in
developing countries.
“Emerging economies are where the action is,” said
Laura A. Schmidt, a professor of health policy at the University of California,
San Francisco. “These are places where the health infrastructure is less established
and populations may be less informed about health hazards
If
corporations can get in on the ground floor, they can shape the narratives and policies
around unhealthy products.”
The
organization’s annual report and website brim with assurances about its
commitment to transparency. According to its code of ethics, ILSI projects
“must address issues of broad public health interest.”
But
the organization has a long history of championing corporate interests. In
2001, a WHO report criticized the group for its role in financing studies that
cast doubt on the dangers of smoking, and in 2006, the agency barred ILSI from
activities involving the setting of standards for food and water after its
stealth efforts to sway policy in favor of industry came to light.
Over
the past decade, ILSI has received more than $2 million from chemical
companies, among them Monsanto NSE -0.35 % , which was bought by Bayer last
year. In 2016, ILSI came under withering criticism after a U.N. committee
issued a ruling that glyphosate, the key ingredient in Monsanto’s weed killer
Roundup, was “probably not carcinogenic,”
contradicting
an earlier report by the WHO’s cancer agency. The committee, it turned out, was
led by two ILSI officials, one of them Alan Boobis, the vice president of
ILSI-Europe who has done consulting work for the chemical sector.
In
India, ILSI’s expanding influence has coincided with mounting rates of obesity,
cardiovascular disease and especially diabetes, which affects more than 70
million Indians. Experts say that number could soar to 123 million in the next
decade as more people embrace processed foods high in fat, sugar and salt.
The
government has responded with bold measures, including a 40% tax on
sugarsweetened soda introduced in 2017. But other efforts, including a ban on
junk food sales in and around schools, have stalled amid opposition from food
and beverage companies.
“The
power of this industry is even greater than that of the tobacco industry,” said
Sunita Narain, the director of the Center for Science and Environment in New
Delhi. Four years ago, she took part in a government panel on warning labels
whose report was promptly shelved. “But they are so shadowy that these players
don’t dare come to the table
representing
the food industry, because no one would accept Coca-Cola or Pepsi in the room.”
ILSI-India
has excelled at getting its allies into the room.
In
addition to Sesikeran’s roles, Dr. Debabrata Kanungo, an ILSI member and former
official with the Indian Ministry of Health, sits on two scientific food
panels: one considering the safety of pesticide residues, and another on
additives in processed foods. Sinha, ILSIIndia’s executive director and an
economist by training, briefly served on a government nutrition panel along
with Sesikeran, but both were removed after they failed to declare
their
relationship with ILSI as a conflict of interest. Even as its influence in the
developing world grows, ILSI has faced occasional pushback.
An
ILSI-funded research project on childhood obesity in Argentina was canceled
three years ago after parents whose children were enrolled in the study learned
more about the organization. And in 2015, ILSI officials in Washington
shuttered ILSI-Mexico after the news media there wrote unfavorably about a
conference it organized on sweeteners.
Many
of the speakers, it turned out, were well-known advocates for the beverage
industry, and at the time, the Mexican government was considering modifications
to a newly enacted tax on sugary drinks.
It
did not help that the head of ILSI-Mexico was Raul Portillo, a former Coca-Cola
executive in charge of regulatory and scientific affairs.
have
now reached bottom and eventually we will recover as Coke and ILSI are concerned,”
he wrote. The suspension, it turns out, lasted less than a year, and
ILSI-Mexico is up and running with
new executive director: J. Eduardo Cervantes, the former director of public
affairs at Coca-Cola of Mexico.
Comments
Post a Comment